Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004139 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,339 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004139 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,335 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004142 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,575 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004142 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004138 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,677.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004138 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,662.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004140 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,241 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004140 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,234 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 15:52 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004135 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,163 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:26 UTC | SaleCommon Stock | 11,724 | $245.07 | $2,873,231.16 |
DisclosureSEC source: 0001225208-25-004011 · doc4.xml · nonDerivative · entry 2 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,064.0271 F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.27 - $246.98, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
|
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Exercise / conversionFY2023 RSUs · Derivative | 444 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · derivative · entry 7 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 444 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 444 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 444 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 444 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 444 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Exercise / conversionFY2022 RSUs · Derivative | 860 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · derivative · entry 6 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 860 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 860 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 860 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 860 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 860 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Tax withholdingCommon Stock | 444 | $244.72 | $108,655.68 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · nonDerivative · entry 5 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,957 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Tax withholdingCommon Stock | 233 | $244.72 | $57,019.76 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · nonDerivative · entry 4 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,401 F3 · price: Represents the amount of shares withheld to cover tax liabilities upon the vesting of 455 performance based Restricted Stock Units that vested and converted into an equal number of shares of common stock on April 1, 2025 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Tax withholdingCommon Stock | 227 | $244.72 | $55,551.44 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · nonDerivative · entry 3 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,634 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Exercise / conversionCommon Stock | 444 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · nonDerivative · entry 2 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 444 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Ghei AshimaInterim CFO
|
Exercise / conversionCommon Stock | 860 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004010 · doc4.xml · nonDerivative · entry 1 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 860 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,903 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004012 · doc4.xml · derivative · entry 3 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 3,903 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 3,903 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 3,903 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Tax withholdingCommon Stock | 1,766 | $244.72 | $432,175.52 |
DisclosureSEC source: 0001225208-25-004012 · doc4.xml · nonDerivative · entry 2 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,138.25 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Jarkowski Hope M.Chief Legal Officer
|
Exercise / conversionCommon Stock | 3,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004012 · doc4.xml · nonDerivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,904.25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 3,903 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 16:26 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Tax withholdingCommon Stock | 259 | $244.72 | $63,382.48 |
DisclosureSEC source: 0001225208-25-004013 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,342.696 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC | Tax withholdingCommon Stock | 15,000 | $244.72 | $3,670,800.00 |
DisclosureSEC source: 0001225208-25-004011 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,788.0271 Read SEC document |
|
| April 01, 2025 Filed Apr 3, 2025 16:26 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Tax withholdingCommon Stock | 604 | $244.72 | $147,810.88 |
DisclosureSEC source: 0001225208-25-004008 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,489.9949 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,511 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004015 · doc4.xml · derivative · entry 4 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,511 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 1,511 Restricted Stock Units vested and converted into an equal number of shares of common stock F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 1,511 Restricted Stock Units vested and converted into an equal number of shares of common stock F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 1,511 Restricted Stock Units vested and converted into an equal number of shares of common stock F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 1,511 Restricted Stock Units vested and converted into an equal number of shares of common stock Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Tax withholdingCommon Stock | 960 | $244.72 | $234,931.20 |
DisclosureSEC source: 0001225208-25-004015 · doc4.xml · nonDerivative · entry 3 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,308.799 F2 · price: Represents the amount of shares withheld to cover tax liabilities upon the vesting of 1,860 performance based Restricted Stock Units that vested and converted into an equal number of shares of common stock on April 1,2025. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Tax withholdingCommon Stock | 772 | $244.72 | $188,923.84 |
DisclosureSEC source: 0001225208-25-004015 · doc4.xml · nonDerivative · entry 2 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,268.799 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Exercise / conversionCommon Stock | 1,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004015 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,040.799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2025 1,511 Restricted Stock Units vested and converted into an equal number of shares of common stock Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Tax withholdingCommon Stock | 4,155 | $244.72 | $1,016,811.60 |
DisclosureSEC source: 0001225208-25-004014 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,368.521 Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:26 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Tax withholdingCommon Stock | 914 | $244.72 | $223,674.08 |
DisclosureSEC source: 0001225208-25-004009 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,222.8948 Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 16:32 UTC |
keller brettDirector
|
GrantCommon Stock | 131 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003506 · doc4.xml · nonDerivative · entry 1 keller brett · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,667 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 16:32 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 181 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003509 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,329 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 16:33 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 131 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003510 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,549 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 16:32 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 131 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003508 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,226 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 16:32 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003507 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,612.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 14:55 UTC | Exercise / conversionStock Option (Right to Buy) · Derivative | 59,395 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-25-003255 · doc4.xml · derivative · entry 5 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,395 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024. Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 14:55 UTC | SaleCommon Stock | 48,974 | $235.18 | $11,517,671.04 |
DisclosureSEC source: 0001225208-25-003255 · doc4.xml · nonDerivative · entry 4 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,788.0271 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.56 - $240.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 14:55 UTC | SaleCommon Stock | 34,101 | $235.90 | $8,044,262.22 |
DisclosureSEC source: 0001225208-25-003255 · doc4.xml · nonDerivative · entry 3 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,762.0271 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.55 - $240.13, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 14:55 UTC | SaleCommon Stock | 12,881 | $235.18 | $3,029,344.56 |
DisclosureSEC source: 0001225208-25-003255 · doc4.xml · nonDerivative · entry 2 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,863.0271 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.56 - $240.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
|
| March 10, 2025 Filed Mar 12, 2025 14:55 UTC | Exercise / conversionCommon Stock | 59,395 | $67.32 | $3,998,471.40 |
DisclosureSEC source: 0001225208-25-003255 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,744.0271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on December 9, 2024. Read SEC document |
|
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,376 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · derivative · entry 9 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,751 Underlying: Common Stock · 9,376 shares Expires 2033-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,549 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · derivative · entry 8 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,549 Underlying: Common Stock · 7,549 shares Expires 2032-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,719 | $0.00 Strike: $148.07 | $0.00 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · derivative · entry 7 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,719 shares Expires 2031-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 8,495 | $235.23 | $1,998,278.00 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 6 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,523.521 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 - $236.43, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 7,021 | $235.23 | $1,651,549.13 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 5 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,018.521 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 - $236.43, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 6,841 | $235.23 | $1,609,207.75 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 4 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,039.521 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 - $236.43, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 7,549 | $144.84 | $1,093,397.16 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,880.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 7,719 | $148.07 | $1,142,952.33 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,331.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 15:33 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 9,376 | $144.67 | $1,356,425.92 |
DisclosureSEC source: 0001225208-25-003180 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,612.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 16:11 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 485 | $237.93 | $115,395.37 |
DisclosureSEC source: 0001225208-25-002610 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · BOMAR II LLC Disclosed balance after: 4,960 Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,753 | $0.00 Strike: $64.89 | $0.00 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · derivative · entry 12 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,753 shares Expires 2026-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.